Creating kingdoms

Analysis of four conserved proteins allows a better prediction of eukaryotic phylogeny.

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The rapidity of the explosive radiation of eukaryote taxa has led to suggestions that relationships among these taxa may never be resolved. But in the 3 November Science, Baldauf et al. propose that the use of sequences other than those of the traditional ribosomal RNA genes offers hope (Science 2000, 290:972-977). Based on the sequences of α-tubulin, β-tubulin, actin, and elongation factor 1-alpha, Baldauf et al. propose a phylogeny of 14 higher order eukaryote taxa. The use of multiple sequence sources dilutes errors arising from horizontal gene transfer, and consideration of multiple genes supports groupings that are not identified by single genes considered in isolation.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform